y04O Antibody

What is y04O Antibody and what organism does it target?

y04O Antibody (CSB-PA340072XA01EDZ) is a research antibody that targets proteins from Enterobacteria phage T4 (Bacteriophage T4) . This antibody recognizes specific protein structures encoded by the phage genome and can be utilized in various immunological detection methods. Unlike onconeural antibodies such as anti-Yo that are associated with paraneoplastic syndromes, y04O is a laboratory-produced reagent designed specifically for bacteriophage research applications . The antibody's target is identified through UniProt accession number P39254, providing researchers with standardized reference information for experimental design and validation.

How does y04O Antibody differ from other bacteriophage T4 antibodies?

y04O Antibody represents one of several antibodies targeting different phage T4 proteins, as evidenced by the catalog listing showing related products such as y04M (P39252), y04F (P07078), and y04B (P07082) . Each of these antibodies recognizes distinct epitopes or proteins within the bacteriophage T4 proteome, allowing for differential analysis of phage components. The specificity of each antibody is determined through rigorous validation processes similar to those used for other research antibodies, including knockout models and cross-reactivity testing . When designing experiments, researchers should consider the specific target protein's function and location within the phage structure to properly interpret results obtained with y04O versus other phage-targeted antibodies.

What validation methods confirm the specificity of y04O Antibody?

Similar to other research antibodies, y04O Antibody should undergo a comprehensive validation process that includes assessment of binding selectivity through multiple methods. Standard validation techniques include Western blot, immunoprecipitation, and immunofluorescence using positive and negative controls . Particularly effective validation employs genetic knockout (KO) models as absolute negative controls - if signal persists in KO samples, this indicates potential non-specific binding . For phage antibodies like y04O, validation may include testing against phage-infected versus uninfected bacterial cells, purified phage proteins, and related phage strains. Recent initiatives like YCharOS highlight the importance of open antibody characterization data, as their studies of 812 antibodies revealed many commercially available antibodies fail specificity tests, underscoring the need for proper validation before experimental use .

What are the optimal protocols for using y04O Antibody in Western blot applications?

When using y04O Antibody for Western blot detection of phage T4 proteins, researchers should optimize several experimental parameters. Begin with sample preparation by isolating proteins from phage-infected bacteria using appropriate lysis buffers that preserve the target protein structure. For gel electrophoresis, use 10-12% SDS-PAGE gels for optimal separation of bacteriophage proteins. After transfer to nitrocellulose or PVDF membranes, block with 5% non-fat milk or BSA in TBST for 1 hour at room temperature. Dilute y04O Antibody according to manufacturer recommendations (typically 1:1000 to 1:5000) in blocking buffer and incubate overnight at 4°C. Following thorough washing with TBST, apply appropriate secondary antibody conjugated to HRP or fluorescent labels. Always include positive controls (purified target protein or infected bacterial lysates) and negative controls (uninfected bacteria or knockout samples) to verify specificity . For enhanced reliability, validate results using complementary techniques such as immunoprecipitation or mass spectrometry.

How can y04O Antibody be effectively used in immunoprecipitation studies?

Immunoprecipitation (IP) with y04O Antibody requires careful consideration of experimental conditions to maintain protein-antibody interactions. First, prepare cell lysates using non-denaturing buffers that preserve protein conformation while effectively solubilizing membrane-associated phage proteins. Pre-clear lysates by incubation with protein A/G beads to remove non-specific binding proteins. For the IP reaction, determine optimal antibody concentration through titration experiments (typically 2-5 μg per reaction) and incubate with lysate overnight at 4°C with gentle rotation. Capture immune complexes using protein A/G beads pre-blocked with BSA, followed by extensive washing to remove non-specifically bound proteins. Elute precipitated proteins using either low pH buffer or by boiling in SDS sample buffer, then analyze by Western blot or mass spectrometry . Include appropriate controls such as an isotype-matched irrelevant antibody to identify non-specific precipitation. This approach allows researchers to study protein-protein interactions involving the y04O target during phage infection cycles.

What considerations are important for immunofluorescence applications with y04O Antibody?

For immunofluorescence detection of bacteriophage T4 proteins using y04O Antibody, cell fixation method significantly impacts epitope accessibility and signal quality. Paraformaldehyde fixation (4%, 15 minutes) preserves cell morphology while maintaining antigen recognition, though some epitopes may require additional permeabilization with 0.1-0.5% Triton X-100. For adherent bacterial cultures, grow cells on poly-L-lysine coated coverslips before infection with bacteriophage T4. Block non-specific binding with 5% normal serum from the same species as the secondary antibody. Apply y04O Antibody at optimized dilution (typically 1:100 to 1:500) and incubate overnight at 4°C in a humidified chamber. Use fluorophore-conjugated secondary antibodies compatible with your microscopy setup, and include DAPI nuclear staining to visualize bacterial cells. Always perform parallel staining with secondary antibody alone to identify background signal, and include uninfected controls to confirm specificity for phage proteins . Z-stack imaging may be necessary to fully capture the distribution of phage proteins throughout infected cells.

How should researchers interpret unexpected molecular weight variations when using y04O Antibody?

When Western blot analysis with y04O Antibody reveals bands at unexpected molecular weights, several factors warrant consideration before concluding non-specific binding. Post-translational modifications of phage proteins, particularly during different stages of infection, may alter apparent molecular weight. Protein degradation during sample preparation can generate fragments that retain antibody-binding epitopes. Alternatively, the target protein may form complexes with bacterial or other phage proteins that resist complete denaturation. To address these possibilities, researchers should perform time-course experiments of phage infection, use multiple protein extraction methods, vary reducing agent concentrations, and compare results with complementary techniques like mass spectrometry. According to YCharOS data on antibody validation, approximately 40% of commercially available antibodies exhibit binding to unexpected protein targets, emphasizing the importance of thorough validation . Experimental controls using viral protein synthesis inhibitors can help distinguish between phage-specific proteins and host responses that might present similar molecular weights.

What are common sources of false positives/negatives when using y04O Antibody, and how can they be mitigated?

False positive results with y04O Antibody may stem from cross-reactivity with bacterial host proteins that share structural similarities with the target phage protein. This is particularly relevant for antibodies targeting phage proteins with conserved domains. Excessive antibody concentration can also increase non-specific binding. To mitigate these issues, researchers should titrate antibody concentration to determine optimal signal-to-noise ratio and employ blocking agents specific to the host bacteria used. False negatives commonly result from epitope masking during fixation or sample preparation, insufficient antigen retrieval, or degradation of the target protein. Using multiple extraction methods and testing different fixation protocols can help overcome these challenges. For both scenarios, validation using knockout controls or competitive binding with purified target protein provides definitive evidence of antibody specificity . Recent comparative studies of antibody validation techniques suggest that using at least two independent validation methods significantly reduces both false positive and negative results when working with research antibodies.

How do experimental conditions affect the sensitivity and specificity of y04O Antibody detection?

The performance of y04O Antibody varies considerably with experimental conditions such as pH, salt concentration, detergent type/concentration, and incubation temperature. Buffer pH between 7.2-7.4 typically provides optimal antibody binding, while extreme pH conditions can denature epitopes or alter antibody conformation. Increasing salt concentration (>150mM NaCl) can reduce non-specific electrostatic interactions but may also weaken specific antibody-antigen binding. For membrane proteins, detergent selection is critical - mild non-ionic detergents like Triton X-100 (0.1%) or NP-40 (0.5%) generally preserve protein structure better than ionic detergents such as SDS. Incubation temperature affects both binding kinetics and specificity; while room temperature incubation accelerates binding, 4°C incubation often improves specificity by reducing low-affinity interactions. Systematic optimization of these parameters is essential, as studies have shown that antibody performance can vary by more than 10-fold under different conditions . Additionally, for phage proteins expressed at different infection stages, synchronization of infection and precise time-point sampling significantly impact detection sensitivity.

How can y04O Antibody be utilized in studying phage-host interactions during infection?

y04O Antibody offers sophisticated applications for investigating phage-host interactions through techniques like proximity labeling and ChIP-seq. By conjugating y04O Antibody with proximity labeling enzymes such as BioID or APEX2, researchers can identify proteins that interact with the target phage protein during various infection stages. This approach reveals the dynamic protein interaction network as bacteriophage T4 commandeers host cellular machinery. For studying DNA-protein interactions involving phage proteins, chromatin immunoprecipitation followed by sequencing (ChIP-seq) with y04O Antibody can map binding sites across the bacterial genome. When combined with RNA-seq analysis of infected cells, this creates a comprehensive picture of how phage proteins regulate host gene expression. Time-course experiments using these techniques have revealed that some phage proteins initially interact with host transcription machinery before recruiting additional phage components, insights impossible to gain through traditional methods . These advanced applications require rigorous validation using the techniques described in questions 1.3 and 3.2 to ensure signal specificity.

What approaches enable quantitative analysis of target protein expression using y04O Antibody?

Quantitative analysis of phage protein expression using y04O Antibody can be achieved through several methodologies with varying precision. For relative quantification, densitometry analysis of Western blots provides a basic approach, though this requires careful normalization to loading controls and falls within a limited dynamic range (typically 10-fold). More precise quantification employs ELISA techniques with purified recombinant target protein as a standard curve, enabling absolute quantification within 5-10% variance. For single-cell analysis of infection heterogeneity, flow cytometry following intracellular staining with y04O Antibody can quantify target protein levels across thousands of individual cells. The most advanced approach combines mass spectrometry with immunoprecipitation (IP-MS) using y04O Antibody, allowing identification and quantification of both the target protein and its interaction partners with sensitivity approaching femtomole levels . For all quantitative applications, parallel analysis of multiple biological replicates and statistical assessment of variation are essential for meaningful interpretation of phage protein expression dynamics.

How can y04O Antibody be adapted for super-resolution microscopy studies of phage infection?

Adapting y04O Antibody for super-resolution microscopy requires specific modifications and considerations to achieve nanoscale visualization of phage protein localization. For STORM/PALM techniques, conjugate y04O Antibody directly with photoswitchable fluorophores like Alexa Fluor 647 or employ secondary antibodies with appropriate labeling density to prevent overcrowding. The direct conjugation approach reduces the linkage error that limits resolution in indirect immunofluorescence. For STED microscopy, pair y04O Antibody with secondary antibodies labeled with photostable dyes such as ATTO 647N or Abberior STAR 635P that withstand the high laser intensities required. Sample preparation becomes increasingly critical at nanoscale resolution - use thin sections (70-100 nm) for infected bacterial cells and optimize fixation protocols to minimize structural artifacts while preserving antigen recognition. Correlative light and electron microscopy (CLEM) approaches combining y04O Antibody immunofluorescence with electron microscopy can provide unprecedented insights into how phage proteins integrate with host cellular structures during infection . These advanced imaging techniques have revealed that some phage proteins form distinct subcellular clusters rather than distributing homogeneously as suggested by conventional microscopy.

How does the performance of y04O Antibody compare with other methods for detecting bacteriophage T4 proteins?

When compared with alternative detection methods for bacteriophage T4 proteins, y04O Antibody offers distinct advantages and limitations researchers should consider when designing experiments. The following table summarizes key performance characteristics:

Antibody-based detection with y04O provides excellent sensitivity for protein detection but requires thorough validation to ensure specificity . Mass spectrometry offers superior specificity and quantitative capability but demands specialized equipment and expertise. Epitope tagging requires genetic modification of phage genomes but delivers excellent specificity. RNA-based detection through qPCR provides transcript-level information but doesn't capture post-transcriptional regulation. Each approach has unique strengths, suggesting that combining complementary methods yields the most comprehensive understanding of phage protein dynamics during infection cycles.

What experimental design considerations maximize reproducibility when using y04O Antibody?

To maximize experimental reproducibility with y04O Antibody, researchers should implement a systematic approach addressing multiple variables that influence antibody performance. First, standardize bacterial culture conditions, including growth phase and media composition, as these factors affect phage infection efficiency and subsequent protein expression. Document detailed infection protocols including multiplicity of infection (MOI), synchronization method, and precise timing of sample collection post-infection. For antibody usage, maintain consistent lot numbers whenever possible, as manufacturing variations can affect specificity profiles. Implement quantitative quality control metrics such as signal-to-noise ratio thresholds and positive control signal intensity to objectively determine experiment validity . Blind analysis of results can reduce unconscious bias in data interpretation. Statistical power analysis should guide sample size determination before beginning experiments. These practices align with recent initiatives like YCharOS that emphasize standardized characterization of research antibodies, as their studies demonstrated that inconsistent validation protocols contribute significantly to reproducibility issues in antibody-based research . Sharing detailed protocols through repositories like protocols.io further enhances research transparency and reproducibility.

How should researchers interpret conflicting results between y04O Antibody detection and other experimental approaches?

When y04O Antibody results conflict with data from alternative methods, systematic troubleshooting and integrative analysis are essential for resolution. First, evaluate the validation evidence for y04O Antibody specificity, particularly in the specific experimental context where discrepancies arise. Consider whether technical artifacts might explain differences - antibody detection depends on epitope accessibility, which varies with protein conformation, while methods like mass spectrometry detect proteins regardless of folding state. Temporal factors may contribute to discrepancies; transcript-level measurements (qPCR) often precede detectable protein accumulation, creating apparent contradictions with immunological detection . Protein turnover rates and post-translational modifications can further complicate comparison between methods. To resolve conflicts, design experiments that directly address possible explanations through time-course studies, subcellular fractionation before analysis, or epitope mapping to identify potential recognition issues. According to YCharOS characterization data, approximately 30% of antibodies demonstrate application-specific performance variations, functioning well in one application (e.g., Western blot) but poorly in others (e.g., immunofluorescence) . This highlights the importance of method-specific validation and awareness that no single experimental approach provides a complete picture of biological reality.